Posts filtered by tags: Pfizer[x]


Dow Jones Tops 30,000 For First Time Ever As Biden Transition Points To More Stable Future

cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p0").init({"mcp":"cbs","width":"100%","height":"100%","video":"4876994","autoplay":false,"accessKey":"5VD6Eyd6djewbCmNwBFnsJj17YAvGRwl","accessControl":{"preview":false},"pInstance":"p0","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"[email protected]","trackingServer":"","customTrack...
Tags: Business, News, Wall Street, Senate, Joe Biden, Economy, Pennsylvania, Treasury, General Services Administration, Astrazeneca, Janet Yellen, Michigan, Pfizer, Federal Reserve, Biden, Stock Market

Oil hits highest since March collapse on vaccine, Biden transition | Reuters

Oil hits highest since March collapse on vaccine, Biden transition | Reuters Oil hit its highest since in March on Tuesday, rising towards $47 a barrel, as a third promising coronavirus vaccine spurred demand recovery hopes and U.S. President-elect Joe Biden received the go-ahead to begin his transition.AstraZeneca said on Monday its COVID-19 shot was 70% effective in trials and could be up to 90% effective, giving the fight against the pandemic a third vaccine. This follows positive results fro...
Tags: Travel, Joe Biden, Astrazeneca, Pfizer, Biden, Reuters, Reuters Oil, Rupert Neil Bumfrey, Tamas Varga, Moderna Brent

How to interpret the 'efficacy' rates of coronavirus vaccines

A volunteer receives an injection for a potential vaccine against COVID-19 at the Baragwanath Hospital on June 28, 2020 in Soweto, South Africa. The vaccine, developed by Oxford University's Jenner Institute, will inoculate 2,000 South Africans. Felix Dlangamandla/Beeld/Gallo Images via Getty Images Vaccine efficacy measures how well a vaccine works at preventing disease among vaccinated people, when compared to unvaccinated individuals. The vaccine efficacy numbers for coronavirus inj...
Tags: Science, News, US, Trends, Public Health, New York Times, Bill Gates, Astrazeneca, Pfizer, Oxford University, Vaccines, Times, Morgan Stanley, Anthony Fauci, Trevor Noah, Gates

6 crucial unanswered questions about AstraZeneca's coronavirus vaccine results

A lower initial dose of the Oxford-AstraZeneca vaccine, would mean double the number of vaccine doses available, once regulators approve it. VINCENZO PINTO/AFP via Getty Images For the third consecutive Monday, a drugmaker said its coronavirus vaccine candidate was successful in late-stage studies. AstraZeneca and the University of Oxford said their two-dose shot was effective at preventing COVID-19, according to preliminary results.  AstraZeneca's news follows similar announcements of suc...
Tags: Health, UK, Science, US, Trends, Getty Images, Analysis, Healthcare, Oxford, Brazil, Astrazeneca, Pfizer, University of Oxford, Biotech, Afp, Pollard

Scientists are puzzling over one crucial number as they evaluate the Oxford-AstraZeneca coronavirus vaccine

Oxford-AstraZeneca's vaccine could be given at half-dose initially. VINCENZO PINTO/AFP via Getty Images The Oxford-AstraZeneca vaccine candidate is 70% effective, on average, according to a press release published on Monday. The vaccine is given as two shots. Efficacy increased to 90% in a smaller group of volunteers who received a half dose in the first shot, then a full dose in the second shot. Experts including Dr. Anthony Fauci, director of the National Institute of Allergy and Inf...
Tags: UK, US, Trends, Britain, South Africa, Oxford, Cambridge, Astrazeneca, Pfizer, University of Oxford, Pascal Soriot, Anthony Fauci, Sarah Gilbert, Gilbert, Fauci, Pollard

Oil hits highest since March, spurred by vaccine hopes | Reuters

Oil hits highest since March, spurred by vaccine hopes | Reuters Oil hit its highest since March on Tuesday, rising towards $47 a barrel, as a third promising coronavirus vaccine spurred hopes of a quicker recovery in economic growth and oil demand next year.AstraZeneca said on Monday its COVID-19 shot was 70% effective in trials and could be up to 90% effective, giving the fight against the pandemic a third vaccine. This follows positive results from Pfizer/BioNTech and Moderna.Brent crude rose...
Tags: Travel, Astrazeneca, Pfizer, Reuters, Reuters Oil, Rupert Neil Bumfrey, Tamas Varga, Moderna Brent

Oil wipes out most of its pandemic losses and hits its highest since March, as a vaccine rollout turns traders bullish on 2021

FILE PHOTO: An oil tanker is seen in the sea outside the Puerto La Cruz oil refinery in Puerto La Cruz Reuters Oil rallied to its highest in eight months, as the likely imminent rollout of a COVID-19 vaccine ignited optimism over a pickup in demand next year. Brent crude futures market shows traders are finally betting on a sustained recovery in global fuel consumption. "Though global oil demand is still well below the 2019 level, the visible path for the coming oil demand rebound is now c...
Tags: UK, Saudi Arabia, Russia, US, Trends, Opec, Astrazeneca, Goldman Sachs, Pfizer, Reuters Oil, International Energy Agency, Organization of the Petroleum Exporting Countries, SEB, ING, Moderna, Puerto La Cruz

The creator of AstraZeneca's coronavirus vaccine is a mom to triplets. Her children participated in the trial.

Sarah Gilbert (top left), chief investigator of the Oxford coronavirus vaccine trial, speaks with Prince William (bottom right). AstraZeneca/Reuters AstraZeneca and the University of Oxford announced Monday that their COVID-19 vaccine was 70% effective, on average. The vaccine's creator, Sarah Gilbert, had faith in its efficacy from the start: Her triplets participated in the UK trial. "This vaccine should do what we always wanted it to do," Gilbert said on Monday. "We wanted a vaccine for...
Tags: UK, Science, News, US, Trends, Bloomberg, Bbc, Middle East, Oxford, Food And Drug Administration, Brazil, Astrazeneca, Pfizer, University of Oxford, William, MERS

University of Sheffield and Pfizer launch new consortium to accelerate development of ATMPs

The University of Sheffield and Pfizer have today (23 November 2020) launched a new consortium which aims to standardize and accelerate the development of Advanced Therapy Medicinal Products (ATMPs), allowing potentially transformative treatments to reach patients sooner.
Tags: Health, Pfizer, University Of Sheffield

Oxford-AstraZeneca’s Covid-19 Vaccine Up to 90% Effective

Preliminary results from the trials of the Covid-19 vaccine jointly developed by the University of Oxford and AstraZeneca indicate that the vaccine’s overall efficacy is 70% but that a regimen that calls for a lower first dose is 90% effective. The preliminary results on the AstraZeneca vaccine were based on a total of 131 Covid-19 cases in a study involving 11,363 participants. The findings were perplexing. Two full doses of the vaccine appeared to be only 62% effective at preventing disease, ...
Tags: Astrazeneca, Pfizer, University of Oxford, Jason Kottke, Moderna, Oxford AstraZeneca

One of Belgium's top virologists offered his family 4 tips for surviving the long COVID-19 winter — read the full letter he wrote them

Guido Vanham and his son Peter Vanham. Peter Vanham Guido Vanham is a virologist, a microbiologist who studies the rapid spreading of viruses, who's been sending letters to his three children throughout the coronavirus pandemic. The text of his most recent letter is printed below with permission from his son, Peter Vanham. In it, Guido Vanham writes that he's optimistic about the latest major vaccine trial updates but warns that if history and previous viruses are any guide, the toughest t...
Tags: Europe, Science, News, Holidays, Opinion, Trends, Belgium, Pfizer, Nordic, Peter, World Economic Forum, Don, Geneva Switzerland, Antwerp Belgium, Nele, Moderna

The value-stock rally won't be as strong as investors expect as bond yields stay low, JPMorgan says

Bloomberg TV JPMorgan Asset Management's Patrik Schöwitz told CNBC on Monday he's not "overly optimistic" on the rotation into value stocks because he expects bond yields to stay low. "Traditionally, you need to see rising bond yields to actually have a big value rally," the global strategist said. "That's partly to do because financials are a big part of the value universe and they like higher bond yields." Schöwitz sees aggressive central bank action limiting the rise of bond yields, lea...
Tags: US, Trends, Investing, Markets, US Treasury, Pfizer, Biden, Morgan Stanley, Cnbc, Jpmorgan, Treasuries, US Treasuries, Bank Stocks, Yields, Value Investing, JPMorgan Asset Management

Goldman Sachs slashes US growth forecasts as spiking coronavirus cases drive economic slowdown

AP Photo/Sue Ogrocki Spiking COVID-19 cases and slowing economic activity have led Goldman Sachs to cut its near-term growth forecasts. US gross domestic product will grow 3.5% in the fourth quarter, down from the previous forecast of 4.5%, said economists led by Jan Hatzius. The bank's first-quarter 2021 growth estimate was also lowered to 1% from 3.5%. Still, the winter drag should give way to a bigger rebound on the back of vaccine distribution, the bank said. Forecasted second-quarter...
Tags: US, Trends, Astrazeneca, Goldman Sachs, Pfizer, University of Oxford, Federal Reserve, Goldman, FOMC, Fed, Moderna, Jan Hatzius, COVID, Ben Winck

Moderna's CEO sold nearly $2 million of his stock ahead of the company's emergency use vaccine filing. He's now worth $3 billion.

Moderna CEO, Stephane Bancel. Andrew Dunn/Business Insider Moderna CEO Stephane Bancel sold almost $2 million in shares ahead of the company's emergency use authorization filing for its COVID-19 vaccine.Bancel sold a total of 19,000 shares between November 18-19 as part of a predetermined trading plan amended May 21, according to a filing with the SEC.Moderna is the second major drug company to announce success in a late-stage COVID-19 vaccine trial. It expects to file for FDA approval by t...
Tags: Trends, Markets, Billionaires, SEC, Stocks, Fda, Pfizer, Goldman, Pharmaceutical, Pharma Company, Moderna, Healthcare Stocks, Stéphane Bancel, Albert Bourla, Coronavirus, Bancel

The Oxford Vaccine Is 70% Effective, Cheaper and Easier To Store and Distribute

AmiMoJo writes: The coronavirus vaccine developed by the University of Oxford is highly effective at stopping people developing Covid-19 symptoms, a large trial shows. Interim data suggests 70% protection, but the researchers say the figure may be as high as 90% by tweaking the dose. The results will be seen as a triumph, but come after Pfizer and Moderna vaccines showed 95% protection. However, the Oxford jab is far cheaper, and is easier to store and get to every corner of the world than the o...
Tags: UK, Tech, Oxford, Astrazeneca, Boris Johnson, Pfizer, University of Oxford, Moderna, Prof Sarah Gilbert

Pfizer and Moderna use mRNA in their COVID-19 vaccines. This never-before-used technology could transform how science fights diseases.

Though messenger RNA technology like Pfizer, Moderna use hasn't grabbed headlines before now, some researchers have been working on it for decades.         [Author: USA TODAY]
Tags: Usa, News, Pfizer, Usa Today, Moderna, Pfizer Moderna

A 3rd coronavirus vaccine works

Hollis Johnson/Business Insider Hello,Another Monday, another batch of vaccine results. This time: AstraZeneca and the University of Oxford shared that their coronavirus vaccine was 70% effective on average. That comes on the heels of Pfizer and its partner BioNTech and Moderna both sharing last week that their coronavirus vaccines were 95% and 94.5% effective, respectively. Moncef Slaoui, the scientific head of Operation Warp Speed, is anticipating things will move quickly from here. He s...
Tags: Science, Massachusetts, US, Trends, Atlantic, Healthcare, Argentina, Astrazeneca, National Institutes of Health, Fda, Pfizer, Vaccine, University of Oxford, Oxford University, Santa, Donald Trump

Oxford University Covid vaccine, cheap and easy to store, is 70-90% effective

Oxford University and AstraZeneca today announced that their Covid vaccine is 70-90% effective depending on the dosing regimen. Though less effective than Pfizer and Moderna's vaccines, the Oxford vaccine is cheap, can be tranpsorted in a cooler, and a single dose can provide immunity. — Read the rest
Tags: Post, News, Oxford, Astrazeneca, Pfizer, Oxford University, Vaccines, Moderna, COVID

Oil jumps to highest since early September on latest sign of vaccine progress

Drone Base/Reuters Oil futures gained to their highest since September 1 on Monday after AstraZeneca announced its coronavirus vaccine was 70% effective at protecting against COVID-19.The shot — developed in partnership with the University of Oxford — showed 90% and 62% effectiveness across two different dosing regimens. It joins Moderna and Pfizer and BioNTech's promising candidates.The news spurred new optimism for a swift economic recovery and stronger oil demand. West Texas Intermediat...
Tags: US, America, Trends, Nvidia, Astrazeneca, Warren Buffett, Goldman Sachs, Wti, Pfizer, University of Oxford, US Food and Drug Administration, Moderna, Ben Winck, Bank of America saysGoldman Sachs

Dow gains 210 points as AstraZeneca results boost COVID-19 vaccine optimism

Sergei Bobylev\TASS via Getty Images US stocks rose on Monday after AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%.This marks the third COVID-19 vaccine that surpassed the FDA's stated threshold requirement of 50% effectiveness.Watch major indexes update live here.US stocks gained on Monday as investor optimism surrounding the development of successful COVID-19 vaccine candidates remained elevated.AstraZeneca said on Monday that its COVID-19 va...
Tags: US, Trends, Astrazeneca, Goldman Sachs, Fda, Pfizer, University of Oxford, Goldman, Dow Jones, TASS, Matthew Fox, Sergei Bobylev, Getty Images Us

Veteran investor Jeremy Grantham discussed the dot-com bubble, green investing, and America's poor handling of the pandemic in a recent interview. Here are the 10 best quotes

Morningstar / YouTube British investor Jeremy Grantham reflected on the dot-com bubble, trumpeted green investments, and criticized Americans' response to the pandemic in a RealVision interview released on Monday.The chief investment strategist of asset-manager GMO also praised Pfizer's partner BioNTech and Moderna for developing extremely effective COVID-19 vaccines in record time.Scroll down to read his 10 best quotes from the interview.Visit Business Insider's homepage for more stori...
Tags: Congress, US, America, Trends, Gmo, Warren Buffett, Pfizer, Goldman, Grantham, Morningstar, Alan Greenspan, Jeremy Grantham, Grantham Mayo van Otterloo, Moderna, BioNtech, General Electrics

Covid: Oxford AstraZeneca vaccine has up to 90% efficacy, data reveals

Vaccine developed in UK by AstraZeneca and Oxford University ‘will save many lives’, says scientistCoronavirus – latest updatesSee all our coronavirus coverageThe Covid vaccine developed in the UK by Oxford University and AstraZeneca can protect 70.4% of people from becoming ill and – in a surprise result – up to 90% if a lower first dose is used, results from the final trial show.The Oxford vaccine is the third to produce efficacy results, following Pfizer/BioNTech and Moderna whose vaccines we...
Tags: Health, UK, Science, US, Society, World news, Medical Research, Infectious Diseases, Oxford, Astrazeneca, Vaccines and immunisation, Pfizer, Oxford University, Moderna, Coronavirus, Oxford AstraZeneca

This COVID vaccine is effective, cheaper and can be transported in a normal refrigerator

By DANICA KIRKA and JILL LAWLESS | Associated Press LONDON — Pharmaceutical company AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. The results are based on interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca. No hospitalizations ...
Tags: Business, London, News, Sport, World news, Soccer, Oxford, Brazil, World Health Organization, Astrazeneca, Vaccinations, Associated Press, Pfizer, Pascal Soriot, Oxford University, Latin America

Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store

Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to dosing, including one where two full strength does were applied, which was 62% effective, and a much more promising dosage trial which used one half-dose and one full strength dose to follow – that one was 90% effective. Oxford’s results may not ...
Tags: Health, TC, Messenger, Medicine, Tech, Medical Research, Oxford, Vaccination, Astrazeneca, Pfizer, Vaccine, Oxford University, Biotech, Vaccines, Moderna, COVID

A Glimmer of Light Ahead for the Aviation Industry

Boeing 737 MAX 7 For the thousands of us who call the aviation industry home, 2020 turned out to be a year we’ll be glad to see the end of although the change of calendars won’t wipe away many of this year’s problems. The highly-contagious coronavirus wreaking havoc on our planet stuck its ugly tentacles into nearly every aspect of life on Earth this year. The result has been people fleeing airline travel and anything related in unprecedented numbers. Airlines around the globe reacted by parkin...
Tags: Congress, Cdc, Washington, US, America, Joe Biden, Earth, First, United States, Aviation, Pfizer, Biden, Donald Trump, Faa, Boeing, Trump

The head of the Trump administration's Operation Warp Speed vaccine effort has had 'no contact' with Biden, and can't share confidential information with the President-elect

Dr. Moncef Slaoui, chief adviser to Operation Warp Speed, speaks in the Rose Garden of the White House, Friday, Nov. 13, 2020, in Washington. AP Photo/Evan Vucci Moncef Slaoui, the head of Operation Warp Speed, said Sunday he has been told not to share any confidential information about the COVID-19 vaccine program with President-elect Joe Biden's team. "I have been informed that I should not be saying anything that is confidential to anybody, including anybody that's not a part of the adm...
Tags: Nbc, Abc, Washington, White House, Trends, Joe Biden, Cnn, United States, Astrazeneca, Pfizer, University of Oxford, Biden, Donald Trump, Trump, US Food and Drug Administration, Rose Garden

Oxford and AstraZeneca's COVID-19 vaccine is considerably cheaper and easier to distribute than either Pfizer's or Moderna's. Here's why.

A half-dose of Oxford-AstraZeneca's COVID-19 vaccine initially could mean we have double the number doses available when it's approved by regulators. Siphiwe Sibeko/Pool via AP The University of Oxford and AstraZeneca's COVID-19 vaccine can be stored at normal fridge temperatures for at least six months. Unlike Pfizer and BioNTech's vaccine, it therefore doesn't require an ultra-cold storage and transport system, making it cheaper to distribute globally. The price per dose is also ...
Tags: Minnesota, US, Trends, Eu, Healthcare, Oxford, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, Welt am Sonntag, Andrew Pollard, Moderna, Siphiwe Sibeko, Stéphane Bancel

AstraZeneca and Oxford University's vaccine is effective at preventing COVID-19, trial results suggest. Here's everything we know so far.

Screen grab taken from video issued by Britain's Oxford University, showing a person being injected as part of the first human trials in the UK to test a potential coronavirus vaccine, untaken by Oxford University in England, Thursday April 23, 2020 Oxford University Pool via AP On Monday, AstraZeneca and The University of Oxford released results for their large-scale trial, which showed their COVID-19 vaccine was 70% effective.  The Oxford vaccine is administered in two doses at least...
Tags: Europe, UK, England, US, Trends, Ap, Bbc, Britain, South Africa, Astrazeneca, Pfizer, University of Oxford, Oxford University, Agency, BBC Radio, Welt am Sonntag

'A new era': Success of Pfizer and Moderna COVID-19 mRNA vaccines a major breakthrough

Coronavirus vaccines from Pfizer and Moderna are based on messenger RNA technology that could transform the way science fights diseases.         [Author: USA TODAY]
Tags: Usa, News, Pfizer, Usa Today, Moderna

Global stocks rise as the US plans first COVID-19 vaccinations by mid-December

Thomson Reuters Global stocks rose on Monday as the head of the White House's Operation Warp Speed said some Americans would be able to receive coronavirus vaccinations by mid-December.Investors are betting that positive developments in trials of COVID-19 vaccines might mean swift regulatory approval and a quick rollout.The greatest potential is in the sectors with scope to "catch up" as the vaccine rollout and policy support facilitate economic recovery, said UBS' Mark Haefele.AstraZeneca...
Tags: Hong Kong, Japan, London, White House, China, Germany, Global, US, Trends, Fda, Pfizer, Goldman, Shanghai Composite, Mark Haefele, Moderna, Steve Mnuchin